How FDA Should Use Its Authority to Regulate Human Cells
FDA should encourage states to be the primary regulators of stem cell procedures.
The Secretary of Energy’s Tariff Proposal Would Be Disastrous
Revising FERC’s open access tariff rules would reverse 40 years of progress.
Regulatory Reform Should Be About Strengthening Legislative Responsibility
Countries like Australia and Canada offer models for reining in delegation of lawmaking authority to agencies.
How the Clean Power Plan’s Repeal Undermines Regulatory Analysis
The Trump Administration’s purported economic justification weakens the credibility of cost-benefit analysis.
Building for Disaster
Data show that more stringent building codes deliver benefits greatly exceeding their costs.
Designing Safety Regulations for High-Hazard Industries
New National Academies of Sciences report offers much-needed clarity about regulatory design decisions.
Concluding Thoughts on Cost-Benefit Analysis and the Public’s Impact in Rulemaking
The Supreme Court’s decision in Michigan v. EPA illustrates that the public has a serious role to play in the rulemaking process.
Cost-Benefit Analysis and Reasoned Agency Decision-Making
Scalia recounts his role in challenging a SEC rule on behalf of the U.S. Chamber of Commerce.
The Value of Public Participation in Rulemaking
Appearing before agencies affords the public an important opportunity to have a genuine impact on the law.
Autonomous Vehicle Bill Leaves Safety Gaps
House bill on autonomous vehicles restricts state policies that could improve safety.
The Legal Risks of Regulating Climate Change at the Subnational Level
State and local regulators will face challenges in trying to pick up the slack after a federal withdrawal from the Paris Agreement.
The CFPB’s Final Arbitration Rule Run Amok
New rule will raise costs, harming businesses, consumers, and the court system.